UNIVERSITY OF FLORIDA
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- Private
- Established
- 1853-01-01
- Employees
- 10K
- Market Cap
- -
- Website
- http://www.ufl.edu
Almond Milk With Vitamin D: Impact on Vitamin D Status
Not Applicable
Completed
- Conditions
- Kidney Failure, ChronicRenal Insufficiency, Chronic
- Interventions
- Dietary Supplement: NanoD4CKDDietary Supplement: MicroD4CKD
- First Posted Date
- 2021-12-21
- Last Posted Date
- 2024-06-10
- Lead Sponsor
- University of Florida
- Target Recruit Count
- 21
- Registration Number
- NCT05165173
- Locations
- 🇺🇸
University of Florida, Gainesville, Florida, United States
The Less is More Study
Not Applicable
Recruiting
- Conditions
- Alcohol Use
- Interventions
- Behavioral: CounselingBehavioral: mHealth
- First Posted Date
- 2021-12-10
- Last Posted Date
- 2024-06-21
- Lead Sponsor
- University of Florida
- Target Recruit Count
- 120
- Registration Number
- NCT05153811
- Locations
- 🇺🇸
University of Miami, Coral Gables, Florida, United States
🇺🇸University of Florida, Gainesville, Florida, United States
Improving Lactation Success in Black Mothers of Critically Ill Infants
Not Applicable
Active, not recruiting
- Conditions
- Insufficient Lactation
- Interventions
- Device: Hands free wearable breast pump
- First Posted Date
- 2021-12-07
- Last Posted Date
- 2024-11-19
- Lead Sponsor
- University of Florida
- Target Recruit Count
- 40
- Registration Number
- NCT05147987
- Locations
- 🇺🇸
University of Florida, Gainesville, Florida, United States
Trial of Preemptive Pharmacogenetics in Underserved Patients
Not Applicable
Recruiting
- Conditions
- Use of Prescription MedicationsPharmacogenetic Testing
- Interventions
- Diagnostic Test: Panel-based pharmacogenetic genotyping
- First Posted Date
- 2021-12-02
- Last Posted Date
- 2023-09-08
- Lead Sponsor
- University of Florida
- Target Recruit Count
- 492
- Registration Number
- NCT05141019
- Locations
- 🇺🇸
UF Health at the University of Florida, Gainesville, Florida, United States
Pervasive Sensing and AI in Intelligent ICU
Recruiting
- Conditions
- Critical IllnessPainDeliriumConfusion
- Interventions
- Other: Video MonitoringOther: Accelerometer MonitoringOther: Noise Level MonitoringOther: Light Level MonitoringOther: Air Quality MonitoringOther: EKG MonitoringOther: Vitals MonitoringOther: Biosample CollectionOther: Delirium Motor Subtyping Scale 4 (DMSS-4)
- First Posted Date
- 2021-11-19
- Last Posted Date
- 2025-01-23
- Lead Sponsor
- University of Florida
- Target Recruit Count
- 400
- Registration Number
- NCT05127265
- Locations
- 🇺🇸
University of Florida Health Shands Hospital, Gainesville, Florida, United States
Trial of Dichloroacetate (DCA) in Glioblastoma Multiforme (GBM)
Phase 2
Recruiting
- Conditions
- Glioblastoma Multiforme
- Interventions
- Genetic: Genotype
- First Posted Date
- 2021-11-15
- Last Posted Date
- 2025-03-04
- Lead Sponsor
- University of Florida
- Target Recruit Count
- 40
- Registration Number
- NCT05120284
- Locations
- 🇺🇸
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, Maryland, United States
🇺🇸Wake Forest University, Winston-Salem, North Carolina, United States
Dysfunctional Myelopoiesis and Myeloid-Derived Suppressor Cells in Sepsis
Recruiting
- Conditions
- Trauma InjurySepsis
- Interventions
- Other: Blood sampling
- First Posted Date
- 2021-11-08
- Last Posted Date
- 2025-03-11
- Lead Sponsor
- University of Florida
- Target Recruit Count
- 450
- Registration Number
- NCT05110937
- Locations
- 🇺🇸
UF Health at Shands hospital, Gainesville, Florida, United States
The Effects of Vibrotactile Stimulation in Patients With Movement Disorders
Not Applicable
Completed
- Conditions
- DystoniaEssential TremorParkinson Disease
- Interventions
- Other: skin surface vibrationOther: light skin surface vibration- SHAM
- First Posted Date
- 2021-11-04
- Last Posted Date
- 2022-09-27
- Lead Sponsor
- University of Florida
- Target Recruit Count
- 40
- Registration Number
- NCT05106816
- Locations
- 🇺🇸
Norman Fixel Institute for Neurological Diseases, Gainesville, Florida, United States
BL Infusion Trial:Beta-lactam Continuous Versus Intermittent Infusion and Associated Bacterial Resistance and Therapy Outcomes in Critically Ill Patients With Severe Pneumonia
Phase 4
Terminated
- Conditions
- Pneumonia
- Interventions
- Drug: Cefepime, Meropenem, or Piperacillin/Tazobactam
- First Posted Date
- 2021-11-01
- Last Posted Date
- 2023-12-12
- Lead Sponsor
- University of Florida
- Target Recruit Count
- 35
- Registration Number
- NCT05102162
- Locations
- 🇺🇸
University of Florida, Gainesville, Florida, United States
The Path Study: Cognitive and Inflammation Targeted Gut-brain Interventions in Alcohol; Probiotics, Alcohol, Transcutaneous Vagus Nerve Stimulation, and HIV Study
Not Applicable
Recruiting
- Conditions
- Gut MicrobiomeCognition
- Interventions
- Device: Transcutaneous Vagal Nerve Stimulation (tVNS)Dietary Supplement: Probiotic Supplement
- First Posted Date
- 2021-10-22
- Last Posted Date
- 2024-05-10
- Lead Sponsor
- University of Florida
- Target Recruit Count
- 80
- Registration Number
- NCT05090267
- Locations
- 🇺🇸
University of Miami, Coral Gables, Florida, United States
© Copyright 2025. All Rights Reserved by MedPath